KFA
SHPH icon

Kelleher Financial Advisors’s Shuttle Pharmaceuticals SHPH Stock Holding History

Kelleher Financial Advisors’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$407 Buy
+60
New +$813 ﹤0.01% 670

Other funds holding SHPH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kelleher Financial Advisors's SHPH Position: Q1 2026 in Review

Kelleher Financial Advisors opened a new position in Shuttle Pharmaceuticals (SHPH) in Q1 2026: 60 shares worth $407. The stake represents ﹤0.01% of the portfolio and ranks #670 among its holdings.

8 funds tracked by Wall St. Rank hold SHPH as of Q1 2026.

  • Kelleher Financial Advisors held 60 shares of Shuttle Pharmaceuticals worth $407 as of Q1 2026.
  • Shuttle Pharmaceuticals was a new Kelleher Financial Advisors position in Q1 2026.
  • Shuttle Pharmaceuticals made up ﹤0.01% of Kelleher Financial Advisors's portfolio in Q1 2026, its #670 holding.
  • 8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2026.

Based on Kelleher Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.